Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation.

Mack, Avram H; Schofield, Hannah-Lise

Mack, Avram H; Schofield, Hannah-Lise.

Mack AH; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Child and Adolescent Psychiatry and Behavioral Sciences, The Children's Hospital of Philadelphia, Pennsylvania. Electronic address: mackah@email.chop.edu.
Schofield HL; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Child and Adolescent Psychiatry and Behavioral Sciences, The Children's Hospital of Philadelphia, Pennsylvania.

Psychosomatics ; 61(6): 859-860, 2020.

Article in English | MEDLINE | ID: covidwho-692311

Subject(s)

Coronavirus Infections/immunology; Cytokine Release Syndrome/immunology; Delirium/immunology; Immunotherapy, Adoptive/adverse effects; Neurotoxicity Syndromes/immunology; Pneumonia, Viral/immunology; Psychomotor Agitation/immunology; Betacoronavirus; COVID-19; Coronavirus Infections/complications; Delirium/etiology; Humans; Neurotoxicity Syndromes/etiology; Pandemics; Pneumonia, Viral/complications; Psychomotor Agitation/etiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Psychomotor Agitation / Immunotherapy, Adoptive / Coronavirus Infections / Neurotoxicity Syndromes / Delirium / Cytokine Release Syndrome Topics: Long Covid Limits: Humans Language: English Journal: Psychosomatics Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google